Convey Health Solutions Holdings (CNVY) Financials

$10.51

$0.00 (0.00%)

As on 28-Oct-2022 09:30EDT

Market cap

$770 Mln

Revenue (TTM)

$366 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	366.21	337.60	282.91	221.15	--	--
Cost of Revenue	223.71	195.32	171.30	124.09	--	--
Gross Profit	142.50	142.28	111.62	97.06	--	--
Operating Expenses	183.66	325.88	107.99	--	--	--
Operating Profit (EBIT)	8.59	11.71	10.45	-24.73	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-4.75	-10.60	-8.40	-36.70	--	--
Provision for Tax	2.20	-0.62	-1.90	-24.15	--	--
Profit after Tax (Net Income)	-6.95	-9.98	-6.46	-13.18	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-6.95	-9.98	-6.46	-13.18	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	530.72	537.75	470.15	469.87	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	316.93	221.76	275.12	288.11	--	--
Current Liabilities	64.06	70.40	97.79	58.79	--	--
Total Liabilities	1,008.22	829.90	843.07	816.78	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	770.54	697.65	717.24	736.59	--	--
Current Assets	141.17	132.25	125.83	80.20	--	--
Total Assets	975.78	829.90	843.07	816.78	--	--
Total Debt*	291.64	190.67	243.28	219.98	--	--
Net Current Assets	77.11	61.86	28.04	21.40	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-2.32	31.56	10.86	--	--
Cash Flow from Investing Activities	--	-12.33	-13.27	-642.14	--	--
Cash from Financing Activities	--	4.41	9.43	664.24	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.09	-0.15	-0.11	--	--	--
Cash EPS ($)	--	0.30	0.35	--	--	--
Adjusted Book Value ($)	--	7.91	7.71	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.03	0.52	--	--	--
Free Cash Flow per Share ($)	--	-0.22	0.36	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-1.38	-0.92	--	--	--
ROE (%)	-1.30	-1.98	-1.37	--	--	--
ROA (%)	-0.76	-1.19	-0.78	--	--	--
EBIT Margin (%)	1.17	-8.27	3.71	7.95	--	--
Net Margin (%)	-1.90	-2.96	-2.28	-5.96	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	16.45	0.19	0.28	--	--	--
EBIT Growth (%)	-52.00	-365.95	-40.34	--	--	--
Net Profit Growth (%)	8.94	-54.41	50.96	--	--	--
EPS Growth (%)	19.86	-0.39	--	--	--	--
Book Value Growth (%)	-13.58	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-56.97	--	--	--	--
Price / Book Value	1.45	1.06	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	25.30	-32.29	--	--	--	--
Close Price ($)	10.40	8.36	--	--	--	--
High Price ($)	11.48	14.29	--	--	--	--
Low Price ($)	3.75	6.01	--	--	--	--
Market Cap ($ Cr)	769.56	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.50	0.35	0.52	0.47	--	--
Short term debt to equity ratio	0.01	0.00	0.01	0.01	--	--
Current Ratio	2.20	1.88	1.29	1.36	--	--
Quick Ratio	1.60	1.68	1.17	1.31	--	--
Interest Coverage	0.64	-1.61	0.56	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	19.54	18.61	17.88	22.20	--	--
Asset Turnover	0.40	0.40	0.34	--	--	--
Receivable days	--	61.35	64.35	81.09	--	--
Inventory Days	--	23.52	15.34	9.71	--	--
Payable days	--	32.89	30.57	21.69	--	--
Cash Conversion Cycle	--	51.98	49.12	69.11	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.